Shantanu Singh is one of the principal investigators at the celebrated Broad Institute of MIT and Harvard. His research is centered around finding “fingerprints” of genes, chemicals and diseases from microscopy images of cells. Which has tremendous applications for drug discovery and curing diseases. I hope you enjoy this episode!
Also check out some more links about his work below:
About the Lab:
- Carpenter-Singh Lab: https://carpenter-singh-lab.broadinstitute.org/
- MIT Technology Review article on Cell Painting / JUMP Consortium: https://www.technologyreview.com/2023/03/03/1069261/a-technique-called-cell-painting-could-speed-drug-discovery/
- Recent review of Cell Painting applications: https://rdcu.be/d2vHH
Resources:
- Cell Painting Gallery (open image datasets): https://www.nature.com/articles/s41592-024-02399-z
- OASIS Consortium (liver toxicity prediction and reducing animal testing): https://oasisconsortium.org/
Additional Reading:
- On our two-PI lab model: https://www.asbmb.org/asbmb-today/people/083122/high-affinity-binding
Andy and his team at Vincere have been doing amazing work over years to figure out the mitochondrial mechanisms that may contribute to Parkinson's and other neurodegenerative diseases. Listen in as we discuss curing Parkinson's, using AI to find new molecules and broader drug discovery.
Andrew White and his team at Future House have one of the most ambitious missions. I'll quote here because I couldn't say it better myself: Our mission is to build an AI scientist, or AI systems, that can automate scientific research and accelerate the pace of discovery, so humanity can find cures for disease, solutions for climate change, and other species-accelerating technologies. Must watch! 👀
What if the biggest breakthroughs in health and biotechnology aren’t waiting on new ideas but on better experiments? In this episode, Michael Florea joins Javier to expose the hidden bottlenecks in animal research, the quiet revolution of automation in the lab, and the radical possibilities of treating DNA itself as medicine. This conversation peels back the curtain on how science really moves forward and why the future of drug development may look nothing like today.
Join my conversation with Matthew "Oki" O'Connor Co-CEO of Cyclarity Therapeutics. We talk about curing cardiovascular disease, radically extending healthy longevity and the drug discovery journey.
Nicholas Runcie of Oxford University and I discuss whether large language models such as ChatGPT can really understand chemistry. Which of course will be essential as we try to use them to find new medicines and materials.
Eva Smorodina, researcher at the University of Oslo and expert in Computational Chemistry, joins me for an interesting conversation about designing antibodies, tools for biology and the future of AI and drug discovery. I hope you will enjoy!
In this episode I talk with the amazing Reason and Mourad from Repair Bio about a cure for cardiovascular disease. Reason serves as CEO and is also a legend in the world of longevity, having run https://www.fightaging.org for a couple of decades. Mourad serves as CSO and is a celebrated researcher with stints at Harvard Medical School and Pfizer.
Google recently announced AI Co-Scientist, a state-of-the-art AI agent turbo-charging research. The Co-Scientist team has already uncovered new liver-fibrosis targets and repurposed drugs for cancer. Don't miss this episode with Vivek Natarajan, Research Lead for Google’s AI Co-Scientist!
From AI and language models to robots, agents and using AI to automate medicine and software engineering. And even beyond: human consciousness and space exploration. This was one of the most fascinating conversations with Massimo Mascaro, AI expert and part of the CTO Office at Google.
I discuss longevity, AI drug discovery and using worms to test longevity therapeutics with Ben Blue, CTO of Ora Biomedical. I hope you enjoy the podcast, remember to like and subscribe!
If we want to live over 150 years and avoid cancer we will need better mechanisms to preserve our genomic integrity. Join my conversation with Benjamin Arya to learn more!
We have not found new antibiotics for decades, even while the world struggles with new strains of bacteria. What can we do about it?
I welcome my good friend Trishan in a fascinating conversation about making healthcare accessible through technology and in particular AI.
A conversation with Dr. Andrii Buvailo, an expert on AI for drug discovery, on how AI can help us find new medicines.
What should we do to prevent Alzheimer's and other neurodegenerative diseases as we age? Join my conversation with Dr. Christin Glorioso from NeuroAge.
Dan and I talk about the history of artificial intelligence, AI, ML, DL, LLMs what are all those and what they have to do with each other? Listen in to find out.
We will talk about AI and drug discovery. Welcome to our new podcast!
